Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Renewed interest in muscular dystrophy].

B Eymard1

  • 1Institut de myologie Hôpital de La Pitié-La Salpêtrière 75651 Paris.

La Revue Du Praticien
|March 27, 2001
PubMed
Summary

Molecular advancements have revolutionized the understanding of muscular dystrophies by identifying gene mutations and protein deficiencies. This allows for precise disease identification and classification, paving the way for genetic counseling and potential molecular therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Limb Girdle Muscular Dystrophy Associated With TRIM32 Variants: A National Cohort Study.

Muscle & nerve·2026
Same author

Congenital myasthenic syndromes by Epsilon subunit mutations: Phenotypic profiles of 17 Algerian families.

Revue neurologique·2024
Same author

Congenital myasthenic syndrome by mutation of the ColQ gene: Phenotypic and evolutionary profile of three Algerian families.

Revue neurologique·2023
Same author

Dystrophic Myopathy of the Diaphragm with Recurrent Severe Respiratory Failure is Congenital Myasthenic Syndrome 11.

Journal of neuromuscular diseases·2023
Same author

Highly asymmetrical distribution of muscle wasting correlates to the heteroplasmy in a patient carrying a large-scale mitochondrial DNA deletion: a novel pathophysiological mechanism for explaining asymmetry in mitochondrial myopathies.

Neuromuscular disorders : NMD·2022
Same author

Dunnigan lipodystrophy syndrome: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins).

Orphanet journal of rare diseases·2022

Area of Science:

  • Neurology
  • Genetics
  • Biochemistry

Context:

  • Muscular dystrophies are a group of inherited muscle-wasting diseases.
  • Traditional diagnosis relied on clinical presentation and limited molecular data.
  • Recent molecular advancements have provided deeper insights into myopathy mechanisms.

Purpose:

  • To highlight the impact of molecular approaches in understanding and classifying muscular dystrophies.
  • To demonstrate how combining clinical, protein, and genetic data enables accurate diagnosis.
  • To introduce a new classification system for autosomal recessive dystrophies.

Summary:

  • Molecular identification of mutated genes and deficient proteins has transformed the study of muscular dystrophies.
  • Integrating clinical phenotype, transmission mode, protein expression (via immunocytochemistry), and gene mutation allows for definitive disease identification.
  • A new classification system for muscular dystrophies has been established, categorizing 3 groups of autosomal recessive dystrophies (calpainopathies, sarcoglycanopathies, dysferlinopathies) based on molecular findings, each linked to a specific clinical phenotype.

Impact:

  • Accurate genetic counseling is now feasible for most muscular dystrophy cases.
  • This molecular understanding opens avenues for future therapeutic strategies, including "molecular repairing."
  • The new classification provides a framework for research and clinical management.

Related Experiment Videos